About ONIVYDE
ONIVYDE was founded in 2013 and is based in Wrexham, United Kingdom. Operations are conducted within the pharmaceutical sector, with a focus on oncology. Liposome injections targeted at pancreatic cancer treatment are developed, and related information is made available through the domain onivyde.com. Activities encompass research, formulation, and dissemination of data on these therapies, supporting clinical applications in the United Kingdom and potentially broader markets.
- Headquarter Wrexham, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ONIVYDE
Detailed funding history for ONIVYDE
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ONIVYDE
ONIVYDE has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ipsen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
Locked | Locked | Locked |
Investor details for ONIVYDE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ONIVYDE
Investment portfolio details for ONIVYDE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ONIVYDE
Detailed financials for ONIVYDE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Onivyde Comparisons
Peer comparison for ONIVYDE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ONIVYDE
Detailed competitors of ONIVYDE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Onivyde
Complete news archive for ONIVYDE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ONIVYDE
ONIVYDE was founded in 2013.
ONIVYDE is headquartered in Wrexham, United Kingdom. It is registered at Wrexham, Wales, United Kingdom.
ONIVYDE was founded in 2013 and is based in Wrexham, United Kingdom. Operations are conducted within the pharmaceutical sector, with a focus on oncology. Liposome injections targeted at pancreatic cancer treatment are developed, and related information is made available through the domain onivyde.com. Activities encompass research, formulation, and dissemination of data on these therapies, supporting clinical applications in the United Kingdom and potentially broader markets.
ONIVYDE has 1 investor. Key investors include Ipsen.